While EBV-specific CD8+ T cells have been previously reported in the CSF of MS and other neuro-inflammatory conditions39–43, the present study used paired TCRαβ analysis to unequivocally demonstrate EBV reactivity of highly enriched and clonally-expanded CD8+ T cell CSF populations in MS. This evidence concerns the gene CD8A and myeloid sarcoma.